Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, et al
Furthermore, the preclinical works which unravel the effects of GLP-1 in ocular dynamics and the preclinical literature regarding GLP-1RA use in the management of several neuro-ophthalmic conditions, including diabetic retinopathy (DR), glaucoma, and idiopathic intracranial hypertension (IIH) are discussed
Not a shortcut: Dr Ambrish Mithal explains the precautions of GLP-1 drugs India embraces GLP-1 medications as a major advance in diabetes and obesity care
each milliliter delivers ionized zinc that the body cannot synthesize and that is required to support hundreds of metallo-enzymes, nucleic-acid stability, and normal immune competence
For additional details, see supplementary information